Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds for Medium Supplement

Items 1-10 of 16

Page
per page
  1. A 83-01
    A3133 A 83-01
     11 Citation
    Summary: ALK inhibitor
      ≥21.1 mg/mL
  2. SB 431542
    A8249 SB 431542
     30 Citation
    Summary: ALK5 inhibitor
  3. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     21 Citation
    Target: p38
    Summary: MAPK inhibitor
  4. Acetylcysteine
    A8356 Acetylcysteine
    Summary: Antioxidant;mucolytic agent
      ≥44.6 mg/mL
  5. Tretinoin (Aberela)
    A8539 Tretinoin (Aberela)
    Target: RAR/RXR
    Summary: retinoic acid, treats acne vulgaris and keratosis pilaris
      insoluble in H2O; ≥11.9 mg/mL
  6. Dorsomorphin 2HCl
    B1372 Dorsomorphin 2HCl
     6 Citation
    Summary: AMPK inhibitor
  7. Forskolin
    B1421 Forskolin
     15 Citation
    Target: Adenylyl Cyclases
    Summary: type I adenylate cyclase agonist
  8. G418 Sulfate (Geneticin, G-418)
    A2513 G418 Sulfate (Geneticin, G-418)
     7 Citation
    Target: Ribosomes
    Summary: Geneticin, G-418 Sulfate
      insoluble in EtOH; insoluble in DMSO; ≥64.6 mg/mL
  9. Nicotinamide
    N1651 Nicotinamide
     1 Citation
    Target: PARP
    Summary: PARP-1 inhibitor
  10. Prostaglandin E2
    B7005 Prostaglandin E2
     2 Citation
    Target: Prostaglandin EP receptors
    Summary: Endogenous prostaglandin
      ≥35.2 mg/mL

Items 1-10 of 16

Page
per page